Safety Study of PI-0824 to Treat Pemphigus Vulgaris

• Status: Completed
• Trial end date: 2005-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if the use of PI-0824 in patients with Pemphigus vulgaris is safe.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peptimmune

Criteria

Currently experiencing a stable disease course and medication regimen. Currently taking daily corticosteroid therapy for PV.